Journal of the American Chemical Society
Article
reaction rate using 19F NMR spectroscopy.38 The treatment of 33
and 36 with 3 equiv of AgOPiv resulted in smooth conversion to
cyclopalladated products 35 and 38. The progress of these
reactions was monitored by 19F NMR spectroscopy. After 5 min,
both substrates 33 and 36 underwent nearly quantitative
conversion to the monopivalate intermediates 34 and 37. Both
intermediates 34 and 37 then underwent relatively slow
conversion to 35 and 38, respectively. The overall reaction rates
for substrates 33 and 36 under these conditions were the same
within the error of measurement. These observations show that
the rate of the overall transformation is not limited by the rate of
the ligand exchange or the availability of the carboxylate ligand and
that either conformational or configurational isomerization is likely
the rate-limiting step in this transformation.
(2) Ryabov, A. D.; Sakodinskaya, I. K.; Yatsimirsky, A. K. J. Chem.
Soc., Dalton Trans. 1985, 2629−2638.
(3) Lafrance, M.; Gorelsky, S. I.; Fagnou, K. J. Am. Chem. Soc. 2007,
129, 14570−14571.
(4) (a) Lapointe, D.; Fagnou, K. Chem. Lett. 2010, 39, 1118−1126.
(b) Gorelsky, S.; Lapointe, D.; Fagnou, K. J. Org. Chem. 2012, 77,
658−668. (c) Gorelsky, S. I.; Stuart, D. R.; Campeau, L.-C.; Fagnou,
K. J. Org. Chem. 2010, 75, 8180−8189. (d) D. García-Cuadrado, D.;
Braga, A. A. C.; Maseras, F.; Echavarren, A. M. J. Am. Chem. Soc. 2006,
128, 1066−1067.
(5) Davies, D. L.; Donald, S. M. A.; Macgregor, S. A. J. Am. Chem.
Soc. 2005, 127, 13754−13755.
(6) For carboxylate-assisted C−H activation at RhIII, see: Rhinehart,
J. L.; Manbeck, K. A.; Buzak, S. K.; Lippa, G. M.; Brennessel, W. W.;
Goldberg, K. I.; Jones, W. D. Organometallics 2012, 31, 1943−1952.
(7) For carboxylate-assisted C−H activation at IrIII, see: (a) Davies,
D. L.; Donald, S. M. A.; Al-Duaij, O.; Macgregor, S. A.; Polleth, M. J.
̈
CONCLUSIONS
■
Am. Chem. Soc. 2006, 128, 4210−4211. (b) Li, L.; Brennessel, W. W.;
This paper describes a detailed investigation of carboxylate-assisted
C−H activation at PdIV centers. As discussed above, we propose a
pathway involving four steps: (1) ligand exchange, (2) Pd−CAryl
bond rotation, (3) configurational isomerization via Berry
pseudorotation, and (4) carboxylate-assisted C−H cleavage. The
feasibility of each of these steps is supported by the experiments
presented above. A key feature of the investigated [(Py3CH)Pd-
(biphenyl)Cl2]X system is the semilabile tridentate tris(2-pyridyl)-
methane ligand. This ligand stabilizes octahedral cationic PdIV
centers toward reductive elimination. However, coordinatively
unsaturated species can be accessed readily via dissociation of a
pyridine arm of the ligand. This ligand dissociation is believed to
facilitate the key ligand exchange and configurational isomerization
steps. Importantly, the extremely mild conditions necessary for
acetate assisted C−H cleavage at PdIV centers renders this process
attractive for applications in catalytic C−H functionalization
processes mediated by high oxidation state palladium. Ongoing
investigations are focused on expanding this reactivity to other
octahedral high valent group 10 metal centers and to conducting
detailed investigations of the factors governing site selectivity in
these transformations.
Jones, W. D. Organometallics 2009, 28, 3492−3500.
(8) For carboxylate-assisted C−H activation at RuII, see: Davies, D.
L.; Al-Duaij, O.; Fawcett, J.; Giardiello, M.; Hilton, S. T.; Russell, D. R.
Dalton Trans. 2003, 4132−4138.
(9) (a) Juwaini, N. A. B.; Ng, J. K. P.; Seayad, J. ACS Catal. 2012, 2,
1787−1791. (b) Wang, X.; Leow, D.; Yu, J.-Q. J. Am. Chem. Soc. 2011,
133, 13864−13867. (c) Hickman, A. J.; Sanford, M. S. ACS Catal.
2011, 1, 170−174. (d) Sibbald, P. A.; Rosewall, C. F.; Swartz, R. D.;
Michael, F. E. J. Am. Chem. Soc. 2009, 131, 15945−15951.
(e) Rosewall, C. F.; Sibbald, P. A.; Liskin, D. V.; Michael, F. E. J.
Am. Chem. Soc. 2009, 131, 9488−9489. (f) Pilarski, L. T.; Selander, N.;
Bose, D.; Szabo, K. J. Org. Lett. 2009, 11, 5518−5521. (g) Hull, K. L.;
Lanni, E. L.; Sanford, M. S. J. Am. Chem. Soc. 2006, 128, 14047−
14049.
(10) Racowski, J. M.; Ball, N. D.; Sanford, M. S. J. Am. Chem. Soc.
2011, 133, 18022−18025.
(11) Examples of PdIV complexes supported by neutral tridentate
(L3-type) ligands: (a) Klaui, W.; Glaum, M.; Wagner, T.; Bennett, M.
A. J. Organomet. Chem. 1994, 472, 355−358. (b) Bennett, M. A.;
Canty, A. J.; Felixberger, J. K.; Rendina, L. M.; Sutherland, C.; Willis,
A. C. Inorg. Chem. 1993, 32, 1951−1958. (c) Brown, D. G.; Byers, P.
K.; Canty, A. J. Organometallics 1990, 9, 1231−1235.
(12) Examples of PdIV tris(pyrazoyl)borate complexes: (a) Campora,
J.; Palma, P.; del Rio, D.; Lopez, J. A.; Alvarez, E. Organometallics 2005,
24, 3624−3628. (b) Canty, A. J.; Jin, H.; Penny, J. D. J. Organomet.
Chem. 1999, 573, 30−35. (c) Canty, A. J.; Jin, H.; Roberts, A. S.;
Skelton, B. W.; White, A. H. Organometallics 1996, 15, 5713−5722.
(13) Examples of PdIV pincer complexes: (a) Vicente, J.; Arcas, A.;
Julia-Hernandez, F.; Bautista, D. Inorg. Chem. 2011, 50, 5339−5341.
(b) Vicente, J.; Arcas, A.; Julia-Hernandez, F.; Bautista, D. Angew.
Chem., Int. Ed. 2011, 50, 6896−6899. (c) Vicente, J.; Arcas, A.; Julia-
Hernandez, F.; Bautista, D. Chem. Commun. 2010, 46, 7253−7255.
(d) Canty, A. J.; Rodemann, T.; Skelton, B. W.; White, A. H.
Organometallics 2006, 25, 3996−4001. (e) Lagunas, M.-C.; Gossage, R.
A.; Spek, A. L.; van Koten, G. Organometallics 1998, 17, 731−741.
(f) Alsters, P. L.; Engel, P. F.; Hogerheide, M. P.; Copijn, M.; Spek, A.
L.; van Koten, G. Organometallics 1993, 12, 1831−1844.
(14) (a) Byers, P. K.; Canty, A. J.; Skelton, B. W.; White, A. H.
Organometallics 1990, 9, 826−832. (b) Byers, P. K.; Canty, A. J.;
Skelton, B. W.; White, A. H. J. Chem. Soc., Chem. Commun. 1987,
1093−1095.
ASSOCIATED CONTENT
* Supporting Information
■
S
Experimental details and crystallographic (CIF) and spectro-
scopic data for new compounds. This material is available free
AUTHOR INFORMATION
Corresponding Author
■
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We thank the NSF (CHE-1111563) for support of this research.
We also acknowledge funding from NSF Grant CHE-0840456 for
X-ray instrumentation. A.M. is a Howard Hughes Medical Institute
International Student Research Fellow.
(15) See pages S231−S235 in Supporting Information Document 4
for full details.
(16) (a) McCall, A. S.; Wang, H.; Desper, J. M.; Kraft, S. J. Am.
Chem. Soc. 2011, 133, 1832−1848. (b) Brown, D. G.; Byers, P. K.;
Canty, A. J. Organometallics 1990, 9, 1231−1235.
(17) The phenyl ring and pyridine rings of the Py3CH ligand in
complex 8 are offset, which is known to be the most favorable π-
stacking geometry. For detailed discussion on π-stacking interactions
and geometries, see: Hunter, C. A.; Sanders, J. M. K. J. Am. Chem. Soc.
1990, 112, 5525−5534.
REFERENCES
■
(1) For recent reviews, see: (a) Lyons, T. W.; Sanford, M. S. Chem.
Rev. 2010, 110, 1147−1169. (b) Ackermann, L. Chem. Rev. 2011, 111,
1315−1345. (c) Yamaguchi, J.; Yamaguchi, A. D.; Itami, K. Angew.
Chem., Int. Ed. 2012, 51, 8960−9009. (d) Neufeldt, S. R.; Sanford, M.
S. Acc. Chem. Res. 2012, 45, 936−946.
G
dx.doi.org/10.1021/ja401557m | J. Am. Chem. Soc. XXXX, XXX, XXX−XXX